50 employees
BioAxone Therapeutic is neuroscience company focused on the development and commercialization of technologies that target Rho signaling.
2000
$12M
from 1 investors over 1 rounds
BioAxone Therapeutic, Inc. raised $12M on May 20, 2005
Investors: Desjardins Entreprises - Capital régional et coopératif